Skip to main content
OpenTrials

Clinical trial condition

Kidney Neoplasms

Explore clinical trials studying Kidney Neoplasms. Study availability and eligibility vary by location and protocol.

1,142 public trials 219 recruiting studies
Refine in advanced search Browse all conditions

Kidney Neoplasms trial results

Completed

Study of Cabozantinib as 2nd Line Treatment in Subjects With Locally Advanced or Metastatic Renal Cell Carcinoma (RCC) With a Clear-Cell Component Who Progressed After 1st Line Treatment With Checkpoint Inhibitors

NCT03945773

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • SALK - Salzburger Landesklinik Salzburg, Austria
  • CHRU Besançon Besançon, France
  • Centre Jean Perrin Clermont-Ferrand, France
  • Centre Léon Bérard Lyon, France
View all 40 locations
View Trial Details
Completed

Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer

NCT02718066

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +32 more
Locations
  • [Site 02] Mayo Clinic Arizona Phoenix, Arizona, United States
  • [Site 11] University of California, San Diego Medical Center La Jolla, California, United States
  • [Site 01] Hematology - Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
  • [Site 09] H. Lee Moffitt Cancer Center and Research Institute, Inc. Tampa, Florida, United States
View Trial Details
Completed

Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor

NCT00379340

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +16 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • USA Health Strada Patient Care Center Mobile, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
View all 227 locations
View Trial Details
Completed

A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

NCT02009449

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Cancer, +64 more
Locations
  • UCLA Medical Hematology & Oncology Los Angeles, California, United States
  • UCSF San Francisco, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
View Trial Details
Completed

A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid Tumors

NCT04773951

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +25 more
Locations
  • Fujian Provincial Cancer Hospital Fuzhou, Fujian, China
  • Tumor Hospital affiliated to Harbin Medical University Harbin, Heilongjiang, China
  • Hunan Cancer Hospital Changsha, Hunan, China
  • Nanjing Drum Tower Hospital Nanjing, Jiangsu, China
View Trial Details
Completed

"Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)"

NCT05410509

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Stanford Cancer Institute Stanford, California, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Thomas Jefferson Health Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions